Peptide Synthesis IndustryThe global peptide synthesis market is poised for significant growth, with its valuation projected to increase from USD 520.0 million in 2023 to an impressive USD 1.1 billion ...
In a significant step towards advancing scientific research, InfinityChem has unveiled its latest research and manufacturing facility in Scottsdale, Arizona. The new facility is primed to produce ...
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551 Singapore Centre of High Field NMR Spectroscopy and Imaging, Nanyang Technological University, 21 Nanyang Link ...
Once they knew the peptides had adhered to the LNPs, the researchers then had to determine whether or not the peptide-functionalized LNPs (pLNPs) actually reached the intended targets in animal ...
Peptide-guided nanoparticles deliver mRNA to neurons. ScienceDaily . Retrieved January 4, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241217130810.htm ...
An affordable EV with solid-state batteries? MG Motor is launching a new semi-solid-state battery-powered EV next year, claiming “the price is not expensive.” Here’s what you can expect.
By converting waste into high-performance aluminum products, the new method, called solid phase alloying, not only enhances material properties but also contributes to environmental sustainability.
“Vibes” is what you might say out loud when you hear the first five seconds of Solid Air, Martyn’s fourth and greatest solo album, and not just because there’s a literal vibraphon ...
AbbVie will also acquire Nimble's peptide synthesis platform, which is used to discover and optimize oral peptide therapeutics. Roche further taps drug discovery spinout's Nimble tech in $1.1B ...
Leveraging a paradigm-shifting peptide drug discovery and development ... The Nimble platform combines massively parallel solid-phase synthesis, unrivaled chemical and structural diversity ...
By converting waste into high-performance aluminum products, the new method, called solid phase alloying, not only enhances material properties but also contributes to environmental sustainability.
Proposed acquisition adds Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral peptide assets across ...